Mandate

Vinge advises BHG Group’s subsidiary Nordic Nest in connection with the acquisition of Svenssons i Lammhult

Vinge has advised BHG Group AB (publ) in connection with its subsidiary Nordic Nest’s acquisition of E. Svenssons i Lammhult AB. The acquisition constitutes a bolt-on acquisition to Nordic Nest, which was acquired by BHG Group in December 2020 and strengthens the operation’s position in relation to premium brands.

Svenssons i Lammhult is a leading Swedish retail chain offering furniture and home furnishings from more than 170 well-known quality brands. In addition to online sales, the company has five stores in Stockholm, Malmö, Gothenburg and Lammhult. Svenssons i Lammhult has approximately 70 employees and the company’s turnover amounted to approximately SEK 260 million in 2020.  

BHG Group is the largest online actor in consumer sales in the Nordic countries and the largest actor in Europe within Home Improvement, which includes both Do It Yourself and home furnishings. More than 100 online destinations as well as over 70 showrooms are included in the group. BHG Group’s e-commerce operations employs approximately 2,000 people and includes more than 100 online destinations and 70 showrooms. The company’s head office is situated in Malmö and the company conducts operations in most European countries. BHG Group is listed on Nasdaq Stockholm.

The transaction is subject to customary approvals by the relevant public authorities.

Vinge’s team consists of Kristian Ford together with, among others, Niklas Törnell, Wilhelm Stenvall, Karin Gynnerstedt, Johanne Örnfeldt Svensson, Philip Åberg and Pär Remnelid (competition law).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026